David McClung - 12 May 2022 Form 4/A - Amendment Insider Report for BioCardia, Inc. (BCDA)

Role
Chief Financial Officer
Signature
/s/ David McClung
Issuer symbol
BCDA
Transactions as of
12 May 2022
Net transactions value
-$22,898
Form type
4/A - Amendment
Filing time
07 Apr 2023, 16:45:05 UTC
Date Of Original Report
18 May 2022
Previous filing
18 Apr 2022
Next filing
11 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $22,898 -17,347 -18% $1.32 79,803 12 May 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connections with the net settlement of RSUs vested on April 14, 2022, and does not represent a sale by the reporting person.
F2 The original Form 4 incorrectly reported that 20,632 shares had been withheld due to a clerical error. The corrected number is reported herein.
F3 The original Form 4 incorrectly reported that 76,518 shares were beneficially owned following the reported transaction. The corrected amount is reported herein.